Cite
HARVARD Citation
Zapata‐Pérez, R. et al. (2021). Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice. FASEB journal. 35 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zapata‐Pérez, R. et al. (2021). Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice. FASEB journal. 35 (4), p. n/a. [Online].